Omeprazole lawsuit banner showing the $425M AstraZeneca settlement from 2023 beside a gavel and scales.

Omeprazole Lawsuit 2026: Prilosec Kidney Claims, the $425M Deal, and Who Can Still File

Quick Answer

  • The lawsuits are real: kidney injury claims over PPIs, including Prilosec, sit in federal MDL 2789 in New Jersey.
  • AstraZeneca’s 2023 deal was $425 million for about 11,000 claims; individual amounts are not public.
  • No public claim deadline exists; your state’s statute of limitations sets your filing window.

The omeprazole lawsuit is real, but it isn’t a class action. Thousands of people sued over kidney injuries tied to proton pump inhibitors (PPIs), including Prilosec. Those cases sit in a federal multidistrict litigation (MDL).

AstraZeneca agreed to pay $425 million in October 2023 to settle about 11,000 Prilosec and Nexium claims. Trackers still count 11,404 active PPI cases in MDL No. 2789 as of September 2026.

This guide covers who may qualify, what proof matters, and what the filings actually say. One surprising detail: AstraZeneca’s own 2026 financial filing still lists remaining Delaware state court claims, with an earliest trial date of September 2026.

The Facts
CaseProton-Pump Inhibitor Products Liability Litigation, MDL No. 2789 (individual lawsuits, not a class action)
StatusLargest settlement reached in 2023; thousands of cases still active
Fund Size$425 million (AstraZeneca, October 2023); $533.5 million across four manufacturers
Est. Per PersonNot yet determined, not published
Claim DeadlineNone announced; state statutes of limitations apply
AdministratorNot publicly named
Proof NeededMedication use records and a documented kidney diagnosis (per law firm criteria, not an official rule)

Is the Omeprazole Lawsuit Real or a Scam?

Yes, the litigation is real. A plaintiffs’ firm announcement, trade press coverage, and AstraZeneca’s SEC filings all confirm it.

The Seeger Weiss firm announced the $425 million AstraZeneca settlement on October 3, 2023. AstraZeneca’s February 2026 financial filing still describes remaining Nexium and Prilosec claims in Delaware state court.

Omeprazole lawsuit banner showing the $425M AstraZeneca settlement from 2023 beside a gavel and scales.

The scam risk lives around the lawsuit, not inside it. Many pages ranking for this topic are written by law firms that want your phone number. That isn’t illegal, but it isn’t neutral reporting either.

Be wary of any message that promises a check. Real settlement money moves through attorneys and court-supervised processes. It doesn’t arrive through a text asking for your bank login.

Is There an Omeprazole Class Action Lawsuit?

No. The Prilosec cases are individual lawsuits grouped in an MDL, not a class action with one claim form. In an MDL, each lawsuit stays its own separate case.

Think of a group tour. Everyone follows one guide and one schedule, but each traveler books and pays separately.

Plenty of law firm pages use the phrase “class action” anyway. People search for it, so firms write it. The AstraZeneca deal resolved individual claims in New Jersey and Delaware, not a single class.

That distinction changes what you can do. There is no public website where anyone can submit a form and wait for a check. You would need to be a plaintiff, usually through a lawyer.

If a notice calls this a class action settlement and gives a claim website, verify it before you share any personal data.

How Much Was the Prilosec Settlement?

AstraZeneca agreed to pay $425 million in October 2023 to settle about 11,000 claims. The company said it admits no wrongdoing and believes the claims lack merit.

Other manufacturers settled too. GlaxoSmithKline, Pfizer, and Procter & Gamble paid a combined $108.5 million, according to plaintiffs’ lawyers.

DefendantVerified AmountDate
AstraZeneca$425 million (about 11,000 claims)October 2023
GlaxoSmithKline, Pfizer, Procter & Gamble$108.5 million combinedAnnounced by October 2023
All settlements to date$533.5 million (per plaintiffs’ firm)October 2023

Takeda, which makes Prevacid and Dexilant, had not settled when plaintiffs’ counsel made that announcement. Its current status is not yet confirmed.

Dividing the fund by the claim count gives a misleading average. Attorney fees, costs, and injury severity all cut into what any one plaintiff receives.

Key Takeaway: The Prilosec litigation is real, it is not a class action, and the biggest verified settlement is AstraZeneca’s $425 million from October 2023.

How Much Could One Person Get From a Prilosec Settlement?

Not yet determined, and not published. No per-person range has been verified for the AstraZeneca deal.

The reason is structural. The settlement resolved individual lawsuits, and the allocation between plaintiffs has not been made public in any source we found.

Mass tort settlements often weigh certain factors. These are typical, not confirmed for this deal:

FactorWhy it can matter
Severity of kidney injuryDialysis or kidney failure usually weighs more than a mild case
Length of omeprazole useLonger documented use strengthens causation arguments
Medical recordsGaps can shrink or sink a claim
Date of diagnosisTiming affects both strength and filing deadlines
Attorney fees and liensThese reduce the amount you keep

Anyone quoting you a dollar figure is guessing. Treat sites that publish a “typical payout” for this case with suspicion unless they cite a court document.

Reality Check: Nobody legitimate will text or call to pay you first. Third-party “claim helpers” who charge upfront fees aren’t needed. Read any attorney fee agreement in writing before you sign.

Do I Qualify for the Prilosec Lawsuit?

You may qualify if you used omeprazole for an extended period and later received a documented kidney diagnosis. No official eligibility rule exists, because no public claims program exists.

Law firm criteria also disagree. One firm’s page says at least 12 months of use. Another says 90 days or longer. Neither is a court rule.

Common criteria on firm pages include:

  • You took Prilosec, Prilosec OTC, or generic omeprazole.
  • A kidney condition was diagnosed during use or within a year after stopping.
  • You can document both the use and the diagnosis.

The conditions named most often are chronic kidney disease, acute interstitial nephritis, and kidney failure. A lawyer decides whether your facts fit. That decision depends on your records, your state, and which company made your pills.

What Proof Do I Need to Join an Omeprazole Lawsuit?

You need proof that you took the drug and proof of the kidney injury. Records beat memory every time.

Start gathering these now:

  • Pharmacy printouts or prescription history showing omeprazole fills
  • Receipts or bank statements for over-the-counter Prilosec
  • Medical records with your kidney diagnosis and dates
  • Lab results showing kidney function over time
  • A list of your doctors and clinics

One firm page adds that expert testimony linking the drug to your injury may be needed. That comes later, and your lawyer arranges it.

Over-the-counter users have the hardest time. Few people keep receipts for a heartburn pill. Pharmacy loyalty accounts, credit card history, and your doctor’s notes can help fill the gap.

How Do I File an Omeprazole Lawsuit?

You file through an attorney, not through a public claim website. Here are the steps most people follow:

  1. Collect your pharmacy, receipt, and medical records.
  2. Write down when you started and stopped omeprazole.
  3. Note the date of your kidney diagnosis.
  4. Check your state’s time limit for injury claims.
  5. Contact an attorney who handles PPI cases.
  6. Ask for the fee agreement in writing.
  7. Read the retainer before you sign it.
  8. Walk away from anyone demanding upfront money.

Most consultations are free, but confirm that before you share records. A good lawyer will tell you plainly if your case looks weak.

Don’t stop taking your medication on your own. Talk to your doctor first.

Is There a Deadline to File a Prilosec Lawsuit?

No single deadline exists, because there is no settlement claim form. Your state’s statute of limitations controls your window.

Omeprazole lawsuit timeline from the October 2023 AstraZeneca deal to the September 2026 Delaware trial date.

Those time limits vary by state. They also depend on facts such as when you were diagnosed. Some states may count from the date you learned of the injury, but rules differ.

That makes the date hard to guess. A missed filing window can end a claim no matter how strong the medical story is.

Think of it like a warranty claim. The product can be defective, but if you wait past the warranty period, the store may refuse the return.

Don’t treat this as a reason to panic. It’s a reason to check your state’s rule this month, not next year.

What Is the Latest Omeprazole Lawsuit Update in 2026?

The latest verified picture is a split case: a major 2023 settlement, plus thousands of cases still active. Trackers report 18,755 lawsuits filed and 11,404 still active as of September 2026.

AstraZeneca’s February 2026 filing adds detail. It says a single case set for trial in March 2026 settled in principle for a non-material amount. It also says the remaining claims sit in Delaware state court, with the earliest trial scheduled for September 2026.

ItemVerified detail
MDLNo. 2789, District of New Jersey
Cases filed (tracker)18,755
Cases active (tracker)11,404
AstraZeneca remaining claimsDelaware state court
Earliest remaining trialSeptember 2026 (per February 2026 filing)

We could not confirm whether that September trial went forward. The tracker numbers also don’t explain why so many cases remain active after an 11,000-claim settlement. Check the court docket for current orders.

Has Procter & Gamble Settled Over Prilosec OTC?

Yes, according to plaintiffs’ counsel. Procter & Gamble, which makes Prilosec OTC, was named among the manufacturers that settled.

Seeger Weiss said GlaxoSmithKline, Pfizer, and Procter & Gamble settled for a combined $108.5 million. The firm did not break out each company’s share in the announcement we reviewed.

Here’s where sources disagree. One tracker site says P&G hasn’t joined a global deal. The plaintiffs’ firm statement says it settled. We rely on the firm’s primary statement and flag the conflict.

Takeda is the clearer holdout. Plaintiffs said in October 2023 that no deal existed with the Prevacid and Dexilant maker. Nothing we found confirms a later agreement.

Omeprazole users should know which brand they took. Prilosec belongs to AstraZeneca, and Prilosec OTC to Procter & Gamble.

When Will Prilosec Settlement Payments Arrive?

Not yet confirmed. No public payment schedule exists for the AstraZeneca deal.

One tracker says payouts are in a distribution phase and some people may be paid before year-end. It cites no court order, so we don’t treat it as verified.

The wait is normal for mass tort deals. Lawyers verify claims, settle liens, and divide money before anyone sees a check.

Compare it to a delayed insurance reimbursement. The insurer has approved the payment, but someone still has to process your paperwork and clear the holds.

If you already have a lawyer, ask them directly. They can tell you where your claim sits. Anyone else offering a payment date probably has no source.

What Does the Omeprazole Lawsuit Claim the Drug Did?

Plaintiffs claim long-term PPI use caused kidney injury, and that manufacturers failed to warn them. The injuries named include chronic kidney disease, acute interstitial nephritis, and end-stage renal disease.

Acute interstitial nephritis is a type of kidney inflammation. Chronic kidney disease is a gradual loss of kidney function. End-stage renal disease can require dialysis.

The central legal claim is failure to warn. Plaintiffs argue makers should have told doctors and patients about the risk earlier and more clearly.

AstraZeneca says the opposite. It maintains the claims lack merit and admits no wrongdoing in its settlement. A settlement is not a finding that the drug caused your injury.

That gap matters when you read headlines. “Settled” means the company chose to end the litigation. It doesn’t mean a court decided the science.

Key Takeaway: Plaintiffs allege failure to warn about kidney harm, AstraZeneca denies wrongdoing, and no court has ruled that omeprazole caused anyone’s injury.

Do Generic Omeprazole and Prilosec OTC Users Count?

Firm pages say yes, but your situation depends on who made your pills. Prilosec, Prilosec OTC, and generic omeprazole all appear in lawyer eligibility lists.

That claim comes from law firm marketing, not a court order. Which company made your specific product can change who you can sue.

Millions of people took generic omeprazole without ever buying the Prilosec brand. If that’s you, find the manufacturer on an old bottle or pharmacy record.

Bring that detail to your first lawyer call. It’s a question for an attorney, and we can’t answer it for you.

Over-the-counter packaging also tells a story. Check your current package for use directions, and compare them with how long you actually took the drug.

What Other PPI Lawsuits Exist Besides Kidney Claims?

Kidney injury is the main claim, but other PPI matters exist. Some are consumer injury claims, and some are government cases.

Medco Health Solutions agreed to pay the Department of Justice $7.9 million over allegations it solicited kickbacks tied to Prilosec, Toprol-XL, and Plendil. That was a government case. It created no claim form for patients.

Some law firms advertise PPI gastric cancer claims. We could not confirm a filed, organized litigation for those claims, so treat them as firm investigations.

Bone fracture and other injury claims have surfaced against PPI makers in the past. Their current status is not yet confirmed.

If your injury isn’t a kidney condition, ask a lawyer whether a separate case exists. Don’t assume the AstraZeneca deal covers you.

What Happens Next in the Omeprazole Lawsuit?

The next verified milestone is the Delaware state court trial setting, with everything else unconfirmed.

  • October 2023: AstraZeneca agreed to the $425 million settlement for about 11,000 claims.
  • September 2026: Earliest remaining Delaware trial, per AstraZeneca’s February 2026 filing. Current status not confirmed.
  • Expected, date unknown: Court orders on the thousands of cases still active in MDL 2789.
  • Expected, date unknown: Any agreement with Takeda. No source confirms one.
  • Ongoing: Individual state filing windows keep running for people without a lawyer.

Frequently Asked Questions

Is there a Prilosec class action lawsuit?

No, the Prilosec cases are individual lawsuits grouped in a federal MDL.
Each case stays separate.
There is no public class claim form.

How much is the omeprazole lawsuit worth?

No per-person amount has been published.
AstraZeneca paid $425 million to settle about 11,000 claims in 2023.
Your amount would depend on your injury, records, and attorney fees.

Can I sue if I took generic omeprazole?

Law firm pages say generic users may qualify.
Which company made your pills can affect who you can sue.
Ask a lawyer to review your records.

What kidney conditions do the lawsuits cover?

The claims name chronic kidney disease, acute interstitial nephritis, and kidney failure.
Your doctor’s diagnosis and dates matter most.
Keep every medical record.

Is there a deadline to file?

No claim deadline exists, because there is no public claims program.
Your state’s statute of limitations sets the window.
Check it soon.

Did AstraZeneca admit Prilosec causes kidney damage?

No, the company admits no wrongdoing.
It says the claims lack merit.
A settlement is not a court finding.

How do I avoid omeprazole lawsuit scams?

Never pay anyone upfront to “release” settlement money.
Verify any notice through the court docket or your own lawyer.
Real attorneys put fee terms in writing.

Should I stop taking omeprazole?

Don’t stop on your own.
Talk to your doctor about your symptoms and alternatives.
Medical decisions belong with your physician.

The smartest move is to gather your pharmacy and medical records now. Check your state’s time limit for injury claims, and talk to a PPI attorney if your kidney diagnosis fits.

Skip anyone promising a payout date. The one firm fact to hold onto: AstraZeneca struck its $425 million deal in October 2023.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *